ProPhase Labs PRPH
OTC PRPH
$0.01 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProPhase Labs (PRPH) Non Operating Investment Income (2021 - 2026)

Updated

ProPhase Labs (PRPH) reported Non Operating Investment Income of $6,000 for Q1 2026.

Analysis

ProPhase Labs (PRPH) Non Operating Investment Income (2021 - 2026) Analysis & Trends

For FY2022, ProPhase Labs posted Non Operating Investment Income of -$76,000.

  • By year, Non Operating Investment Income came in at -$240,000 in FY2021 and $1.89 million in FY2020.
  • The Q1 2026 figure ranks as the highest quarterly Non Operating Investment Income since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 ProPhase Labs 155,925.56 -390,074.44 226,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 6,000.00
Jun 30, 2025 -823,000.00
Mar 31, 2022 37,000.00
Jun 30, 2021 -67,000.00
Mar 31, 2021 -11,000.00
API Access

ProPhase Labs Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PRPH&period=max&api_key=YOUR_API_KEY